Conditions: ADHD
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 142
Healthy volunteers: no

Brief summary:
To evaluate the efficacy of LDX compared to placebo in adults with ADHD in the adult workplace environment (AWE) setting

Detailed description:
This study has both an optimization and double-blind period

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: LDX intervention 2: Placebo
Intervention descriptions: intervention 1: oral, 30, 50, or 70 mg once-daily for 4 weeks during dose optimization, and then for 1 week during each crossover during the adult workplace environment setting intervention 2: Placebo administered once-daily for one week during the adult workplace environment setting

Protocol document: